References
- Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:202–7.
- Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004;4:423–36.
- Furusaka T, Amamiya K, Iizuka N, Okazaki K, Okazaki M, Okuda Y, Efficacy and compliance of consecutive daily low-dose S-1 therapy. J Jap Soc Cancer Ther 2008;43:529.
- Furusaka T, Iizuka N, Okazaki K, Okazaki M, Okuda Y, Kijima T, Safety and efficacy of consecutive daily low-dose S-1 therapy after radical treatment of head and neck cancer. J Jap Soc Cancer Ther 2009;44:795.
- Tsukuda M, Ogasawara H, Kaneko S, Komiyama S, Horiuchi M, Inuyama Y, A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group. Gan To Kagaku Ryoho 1994;21:1169–77.
- Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. Clin Cancer Res 2005;5:2000–5.
- Yamada Y, Hamaguchi T, Goto M, Muro K, Matumura Y, Shimada Y, Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil. Br J Cancer 2003;89:816–20.
- Tsukuda M, Kida A, Fujii M, Kono N, Yoshihara T, Hasegawa Y, Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer 2005;93:884–9.
- Cho H, Konishi K, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1. Gastric Cancer 2003;6(Suppl 1):24–7.
- Inaba Y, Hayashi K, Miura T, Moriya T, Takiguchi M, Isobe H, Clinical study of S-1 for advanced gastric cancer after reduction surgery. Gan To Kagaku Ryoho 2007;37:1053–7.